Anand Pathak

1.7k total citations
25 papers, 395 citations indexed

About

Anand Pathak is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Anand Pathak has authored 25 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Surgery and 9 papers in Oncology. Recurrent topics in Anand Pathak's work include Testicular diseases and treatments (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Acute Myeloid Leukemia Research (2 papers). Anand Pathak is often cited by papers focused on Testicular diseases and treatments (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Acute Myeloid Leukemia Research (2 papers). Anand Pathak collaborates with scholars based in United States, India and Greece. Anand Pathak's co-authors include Francis D. Pien, Douglas R. Stewart, Mark H. Greene, Jennifer T. Loud, Shenghui Tang, Richard Pazdur, Laleh Amiri‐Kordestani, Francisca Reyes Turcu, Julia A. Beaver and Hui Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and The FASEB Journal.

In The Last Decade

Anand Pathak

24 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anand Pathak United States 11 153 134 66 53 47 25 395
Dominique Cazals France 9 138 0.9× 247 1.8× 44 0.7× 63 1.2× 60 1.3× 11 525
T Furukawa Japan 8 128 0.8× 120 0.9× 48 0.7× 39 0.7× 24 0.5× 25 397
Gaosheng Huang China 13 152 1.0× 122 0.9× 35 0.5× 68 1.3× 55 1.2× 35 432
Shona Pendse United States 9 169 1.1× 223 1.7× 36 0.5× 38 0.7× 12 0.3× 11 457
Christian Monnerat Switzerland 14 187 1.2× 361 2.7× 95 1.4× 66 1.2× 106 2.3× 34 645
Megan Karwan United States 6 140 0.9× 78 0.6× 29 0.4× 77 1.5× 78 1.7× 8 481
Sara R. Rashkin United States 8 134 0.9× 88 0.7× 122 1.8× 57 1.1× 48 1.0× 16 379
M. Brandely France 14 119 0.8× 262 2.0× 37 0.6× 44 0.8× 25 0.5× 36 760
Ornella Carminati Italy 8 56 0.4× 329 2.5× 65 1.0× 33 0.6× 64 1.4× 13 445
Takao Katsube Japan 9 148 1.0× 105 0.8× 37 0.6× 23 0.4× 25 0.5× 17 451

Countries citing papers authored by Anand Pathak

Since Specialization
Citations

This map shows the geographic impact of Anand Pathak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anand Pathak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anand Pathak more than expected).

Fields of papers citing papers by Anand Pathak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anand Pathak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anand Pathak. The network helps show where Anand Pathak may publish in the future.

Co-authorship network of co-authors of Anand Pathak

This figure shows the co-authorship network connecting the top 25 collaborators of Anand Pathak. A scholar is included among the top collaborators of Anand Pathak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anand Pathak. Anand Pathak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pathak, Anand, et al.. (2023). Autophagy indicators in oral squamous cell carcinoma. Pathology. 56(1). 59–64. 2 indexed citations
3.
Desai, Chirag, et al.. (2022). A review on mechanisms of resistance to PARP inhibitors. Indian Journal of Cancer. 59(Suppl 1). S119–S129. 13 indexed citations
4.
Arora, Shaily, Sanjeeve Balasubramaniam, Hui Zhang, et al.. (2020). FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer. The Oncologist. 26(1). e164–e172. 127 indexed citations
5.
Pathak, Anand, et al.. (2020). A predictive and prognostic biomarker profile of carcinoma breast. Indian Journal of Pathology and Oncology. 7(1). 10–13.
6.
Machiela, Mitchell J., Casey Dagnall, Anand Pathak, et al.. (2017). Mosaic chromosome Y loss and testicular germ cell tumor risk. Journal of Human Genetics. 62(6). 637–640. 27 indexed citations
7.
Pathak, Anand, Katja Seipel, Alexander Pemov, et al.. (2015). Whole exome sequencing reveals a C-terminal germline variant in CEBPA-associated acute myeloid leukemia: 45-year follow up of a large family. Haematologica. 101(7). 846–852. 33 indexed citations
8.
Pathak, Anand, Alexander Pemov, Mary L. McMaster, et al.. (2015). Juvenile myelomonocytic leukemia due to a germline CBL Y371C mutation: 35-year follow-up of a large family. Human Genetics. 134(7). 775–787. 18 indexed citations
9.
Pathak, Anand, Douglas R. Stewart, Fábio R. Faucz, et al.. (2015). Rare inactivating PDE11A variants associated with testicular germ cell tumors. Endocrine Related Cancer. 22(6). 909–917. 15 indexed citations
10.
Pathak, Anand, et al.. (2015). Prospectively Identified Incident Testicular Cancer Risk in a Familial Testicular Cancer Cohort. Cancer Epidemiology Biomarkers & Prevention. 24(10). 1614–1621. 3 indexed citations
11.
12.
Chen, Guoli, Xiaoyang Zhou, Anand Pathak, Gerald W. Dorn, & Evangelia G. Kranias. (2008). The Human G147D-Protein Phosphatase 1 Inhibitor-1 Polymorphism Is Not Associated with Altered Clinical Characteristics in Heart Failure. Cardiology. 112(3). 224–231. 2 indexed citations
13.
Chen, Guoli, Xiaoyang Zhou, Persoulla Nicolaou, et al.. (2008). A human polymorphism of protein phosphatase‐1 inhibitor‐1 is associated with attenuated contractile response of cardiomyocytes to β‐adrenergic stimulation. The FASEB Journal. 22(6). 1790–1796. 14 indexed citations
14.
Najem, B., Philippe Unger, Nicolas Preumont, et al.. (2006). Sympathetic control after cardiac resynchronization therapy: Responders vs nonresponders. Journal of Hypertension. 24. 1 indexed citations
15.
Pathak, Anand & Harshad Kulkarni. (2006). Weekly methotrexate in squamous cell cancers of head and neck. Journal of Clinical Oncology. 24(18_suppl). 15539–15539. 2 indexed citations
16.
Galinier, Michel, Anand Pathak, & Jérôme Roncalli. (2006). [Angiotensin receptor blockers and cardiac rhythm disorders].. PubMed. 99(7-8). 745–7. 4 indexed citations
17.
Pathak, Anand, et al.. (1998). Amphotericin B Use in a Community Hospital, with Special Emphasis on Side Effects. Clinical Infectious Diseases. 26(2). 334–338. 52 indexed citations
18.
Pathak, Anand, Suresh H. Advani, Suresh K. Pai, et al.. (1993). Adjuvant chemotherapy for osteogenic sarcoma of the extremity with sequential adriamycin and cisplatin. Journal of Surgical Oncology. 52(3). 181–184. 6 indexed citations
19.
Pathak, Anand, et al.. (1992). Long‐term right atrial catheters in patients with malignancies: An Indian experience. Journal of Surgical Oncology. 51(3). 183–187. 2 indexed citations
20.
Pathak, Anand, et al.. (1992). Urinary Bladder Cancer Following Cyclophosphamide Therapy for Hodgkin's Disease. Leukemia & lymphoma. 8(6). 503–504. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dominique Cazals Breakdown of academic impact, for papers by T Furukawa Breakdown of academic impact, for papers by Gaosheng Huang Breakdown of academic impact, for papers by Shona Pendse Breakdown of academic impact, for papers by Christian Monnerat Breakdown of academic impact, for papers by Megan Karwan Breakdown of academic impact, for papers by Sara R. Rashkin Breakdown of academic impact, for papers by M. Brandely Breakdown of academic impact, for papers by Ornella Carminati Breakdown of academic impact, for papers by Takao Katsube
Rankless by CCL
2026